Truist Securities Upgrades Global Blood Therapeutics (GBT) to Buy

August 4, 2021 4:04 AM EDT
Get Alerts GBT Hot Sheet
Price: $25.57 -3.58%

Rating Summary:
    20 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 5 | New: 36
Trade Now! 
Join SI Premium – FREE

Truist Securities analyst Joon Lee upgraded Global Blood Therapeutics (NASDAQ: GBT) from Hold to Buy with a price target of $50.00 (from $45.00).


For an analyst ratings summary and ratings history on Global Blood Therapeutics click here. For more ratings news on Global Blood Therapeutics click here.


Shares of Global Blood Therapeutics closed at $26.89 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades